AmSurg, Evolution Health and other industry-leading organizations gathered at a GI Research Summit, March 2 at Envision Healthcare's Nashville, Tenn. headquarters, to discuss how to study and leverage GIQuIC data in pursuit of Healthcare Quadruple Aim.
Here's what you should know.
1. The collaboration yielded three potential hypotheses. The hypotheses focus on socioeconomic factors related to colon cancer screening, social determinants that contribute to screening rates and colon cancer screenings' cost.
2. AmSurg's contributions to the GIQuIC database surpassed one million procedures in 2017.
3. Envision Healthcare Chief Quality Officer Gerald Macciolo, MD, said, "We believe we have a moral obligation to investigate our exceptional database and convert it to useful hypotheses and, ultimately, meaningful action."
4. AmSurg's Chief Information Officer Eric Thrailkill said AmSurg's size allows the company to better conduct this level of analysis.
More articles on gastroenterology:
Minnesota Safety Council recognizes Takeda for workplace safety — 4 key notes
NJ administrators expect Allergan to make $385M+ impact over 20 years & more: 4 GI companies in the news
GI leader to know: Dr. Benjamin Schaus of Buffalo Gastroenterology Associates